Michael J. Gubbins

Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus

Jody D. Berry, Steven J.M. Jones, Michael Drebot et al. · Journal of Virological Methods · 2004 · 123 citations · Full text

Pharmacy, Immunology, Infectious Diseases +12

Crystal structure of the bacterial conjugation repressor finO.

J.N.M. Glover, Alexandru F. Ghetu, Michael J. Gubbins et al. · Nature Structural Biology · 2000 · 49 citations

Life Sciences, Biochemistry, Molecular Biology +10

Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of<i>Bacillus anthracis</i>protective antigen

Michael J. Gubbins, Jody D. Berry, Cindi R. Corbett et al. · FEMS Immunology & Medical Microbiology · 2006 · 44 citations

Pharmacy, Immunology, Infectious Diseases +17

The Positive Regulator, TraJ, of the <i>Escherichia coli</i> F Plasmid Is Unstable in a <i>cpxA</i> * Background

Michael J. Gubbins, Isabella C. Y. Lau, William R. Will et al. · Journal of Bacteriology · 2002 · 42 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

An Integrative Bioinformatic Approach for Studying Escape Mutations in Human Immunodeficiency Virus Type 1<i>gag</i>in the Pumwani Sex Worker Cohort

Harold O. Peters, Mark Mendoza, Rupert Capiña et al. · Journal of Virology · 2007 · 32 citations · Full text

Life Sciences, Bioinformatics, Immunology +17